• 1
    Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993; 15: 3647.
  • 2
    Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease. Lancet 2002; 360: 18795.
  • 3
    Kawai M, Minami Y, Kuriyama S et al. Reproductive factors, exogenous female hormone use and breast cancer risk in Japanese: the Miyagi Cohort Study. Cancer Causes Control 2010; 21: 13545.
  • 4
    Goodman MT, Cologne JB, Moriwaki H, Vaeth M, Mabuchi K. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors. Prev Med 1997; 26: 14453.
  • 5
    Hirose K, Tajima K, Hamajima N et al. Impact of established risk factors for breast cancer in nulligravid Japanese women. Breast Cancer 2003; 10: 4553.
  • 6
    Hirose K, Tajima K, Hamajima N et al. A large-scale, hospital-based case-control study of risk factors of breast cancer according to menopausal status. Jpn J Cancer Res 1995; 86: 14654.
  • 7
    Minami Y, Ohuchi N, Fukao A, Hisamichi S. Risk factors for breast cancer: a case-control study of screen-detected breast cancer in Miyagi Prefecture, Japan. Breast Cancer Res Treat 1997; 44: 22533.
  • 8
    Nagata C, Hu YH, Shimizu H. Effects of menstrual and reproductive factors on the risk of breast cancer: meta-analysis of the case-control studies in Japan. Jpn J Cancer Res 1995; 86: 9105.
  • 9
    Sorlie T, Tibshirani R, Parker J et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 2003; 100: 841823.
  • 10
    Cotterchio M, Kreiger N, Theis B, Sloan M, Bahl S. Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup. Cancer Epidemiol Biomarkers Prev 2003; 12: 105360.
  • 11
    Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG. Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 2000; 151: 70314.
  • 12
    Ma H, Bernstein L, Pike MC, Ursin G. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res 2006; 8: R43.
  • 13
    Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev 2004; 13: 155868.
  • 14
    Bao PP, Shu XO, Gao YT et al. Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study. Am J Epidemiol 2011; 174: 66171.
  • 15
    Iwasaki M, Otani T, Inoue M, Sasazuki S, Tsugane S. Role and impact of menstrual and reproductive factors on breast cancer risk in Japan. Eur J Cancer Prev 2007; 16: 11623.
  • 16
    Islam T, Matsuo K, Ito H et al. Reproductive and hormonal risk factors for luminal, HER2-overexpressing, and triple-negative breast cancer in Japanese women. Ann Oncol 2012; doi: 10.1093/annonc/mdr613 [Epub ahead of print].
  • 17
    Yoo KY, Tajima K, Miura S et al. Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case-control analysis. Am J Epidemiol 1997; 146: 30714.
  • 18
    Kawai M, Minami Y, Nishino Y, Fukamachi K, Ohuchi N, Kakugawa Y. Body mass index and survival after breast cancer diagnosis in Japanese women. BMC Cancer 2012; 12: 149.
  • 19
    Minami Y, Tateno H. Associations between cigarette smoking and the risk of four leading cancers in Miyagi Prefecture, Japan: a multi-site case-control study. Cancer Sci 2003; 94: 5407.
  • 20
    Minami Y, Tochigi T, Kawamura S et al. Height, urban-born and prostate cancer risk in Japanese men. Jpn J Clin Oncol 2008; 38: 20513.
  • 21
    Minami Y, Nishino Y, Kawai M, Kakugawa Y. Being breastfed in infancy and adult breast cancer risk among Japanese women. Cancer Causes Control 2012; 23: 38998.
  • 22
    Kakugawa Y, Minami Y, Tateno H, Inoue H, Fujiya T. Relation of serum levels of estrogen and dehydroepiandrosterone sulfate to hormone receptor status among postmenopausal women with breast cancer. Breast Cancer 2007; 14: 26976.
  • 23
    Yamashita H, Iwase H, Toyama T et al. Estrogen receptor-positive breast cancer in Japanese women: trends in incidence, characteristics, and prognosis. Ann Oncol 2011; 22: 131825.
  • 24
    Rakha EA, El-Sayed ME, Green AR et al. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype. J Clin Oncol 2007; 25: 47728.
  • 25
    Andrieu N, Duffy SW, Rohan TE et al. Familial risk, abortion and their interactive effect on the risk of breast cancer–a combined analysis of six case-control studies. Br J Cancer 1995; 72: 74451.
  • 26
    Russo J, Balogh GA, Heulings R et al. Molecular basis of pregnancy-induced breast cancer protection. Eur J Cancer Prev 2006; 15: 30642.
  • 27
    Prat A, Perou CM. Mammary development meets cancer genomics. Nat Med 2009; 15: 8424.
  • 28
    Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease. Lancet 2001; 358: 138999.
  • 29
    Miki Y, Swensen J, Shattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 6671.
  • 30
    Lakhani SR, Van De Vijver MJ, Jacquemier J et al. The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 2002; 20: 23108.
  • 31
    Rothman KJ, Greenland S, Lash TL. Modern Epidemiology, 3rd edn. Philadelphia, London: Lippincott Williams & Wilkins, 2008.
  • 32
    Nomura Y, Miura S, Koyama H et al. Relative effect of steroid hormone receptors on the prognosis of patients with operable breast cancer. a univariate and multivariate analysis of 3089 Japanese patients with breast cancer from the Study Group for the Japanese Breast Cancer Society on Hormone Receptors and Prognosis in Breast Cancer. Cancer 1992; 69: 15364.
  • 33
    Kawai M, Minami Y, Kakizaki M et al. Alcohol consumption and breast cancer risk in Japanese women: the Miyagi Cohort study. Breast Cancer Res Treat 2011; 128: 81725.
  • 34
    Kawai M, Minami Y, Kuriyama S et al. Adiposity, adult weight change and breast cancer risk in postmenopausal Japanese women: the Miyagi Cohort Study. Br J Cancer 2010; 103: 14437.